February 7, 2018 / 10:52 AM / 2 months ago

BRIEF-Livzon Pharmaceutical Group To Sell 51% Stake In Livzon Mab To Biologics Ltd

Feb 7 (Reuters) - Livzon Pharmaceutical Group Inc :

* ‍APPROVED TRANSACTION IN RESPECT OF CHANGE IN SHAREHOLDING STRUCTURE OF LIVZON MABPHARM INC​

* CO TO SELL 51% EQUITY INTERESTS IN LIVZON MAB TO BIOLOGICS LIMITED

* ‍LIVZON INTERNATIONAL & JOINCARE BVI TO CONTRIBUTE TO LIVZON BIOLOGICS RMB306 MILLION AND RMB294 MILLION RESPECTIVELY​

* ‍BIOLOGICS LIMITED AGREED TO ACQUIRE 49% EQUITY INTERESTS IN LIVZON MAB FROM JOINCARE​ Source text for Eikon: Further company coverage: (bangalore.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below